Njira Lugogo, MD (IMAGE)
Caption
The premise of PASSAGE was to focus on underrepresented populations, and to gather more evidence so that we can be more confident in using tezepelumab in these patients: Dr. Lugogo
Credit
ATS
Usage Restrictions
None
License
Original content